BiotechTube

ZL-2306(nirapairb) + Placebo

Phase 3Terminated
0 watching 0 views this week📈 Rising
72
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Extensive-stage Small Cell Lung Cancer

Conditions

Extensive-stage Small Cell Lung Cancer

Trial Timeline

Aug 20, 2018 → Mar 20, 2020

NCT ID
NCT03516084

About ZL-2306(nirapairb) + Placebo

ZL-2306(nirapairb) + Placebo is a phase 3 stage product being developed by Zai Lab for Extensive-stage Small Cell Lung Cancer. The current trial status is terminated. This product is registered under clinical trial identifier NCT03516084. Target conditions include Extensive-stage Small Cell Lung Cancer.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT03516084Phase 3Terminated

Competing Products

20 competing products in Extensive-stage Small Cell Lung Cancer

See all competitors
ProductCompanyStageHype Score
Ifinatamab Deruxtecan (I-DXd)Daiichi SankyoPhase 2
52
Valemetostat + AtezolizumabDaiichi SankyoPhase 1
33
SHR-1316 + Carboplatin + Etoposide + PlaceboJiangsu Hengrui MedicinePhase 3
77
Neoantigen DNA vaccine + DurvalumabAstraZenecaPhase 2
52
Etoposide with Carboplatin or Cisplatin + DurvalumabAstraZenecaPhase 2
52
Durvalumab 50 MG/1 ML Intravenous Solution + Etoposide Injection + Cisplatin + CarboplatinAstraZenecaPhase 1
33
Durvalumab and Tremelimumab + AZD1775 and carboplatin (CBPT) + AZD6738 and olaparibAstraZenecaPhase 2
52
Durvalumab + Cisplatin + Carboplatin + EtoposideAstraZenecaPhase 3
77
Atezolizumab 1200 mg in 20 ML Injection + ADC Vaccine + CarboplatinRochePhase 1/2
41
Tarlatamab + DurvalumabAmgenPhase 3
76
Carfilzomib + Carboplatin + EtoposideAmgenPhase 1/2
40
Tafolecimab + Sintilimab (approved) + Etoposide + Carboplatin / CisplatinInnovent BiologicsPhase 2
51
Pumitamig + Atezolizumab + Etoposide + Carboplatin (or cisplatin if carboplatin is not tolerated)Bristol Myers SquibbPhase 3
76
BMS-986489 (BMS-986012+Nivolumab) + Atezolizumab + Carboplatin + EtoposideBristol Myers SquibbPhase 3
76
BMS-986012 + Carboplatin + Etoposide + NivolumabBristol Myers SquibbPhase 2
51
Ivonescimab + Cadonilimab + AK117 + Etoposide + Carboplatin (AUC 5)AkesoPhase 2
51
Teniposide administrationChina Resources Pharmaceutical GroupPhase 2
49
BNT327 Dose Level 1 (DL1) + BNT327 Dose Level 2 (DL2) + Etoposide + Carboplatin + Paclitaxel + TopotecanBioNTechPhase 2
49
ZepzelcaJazz PharmaceuticalsPre-clinical
20
Lurbinectedin + DurvalumabJazz PharmaceuticalsPhase 2
49

Other Products from Zai Lab

ZL-1310 + Investigator's Choice of TherapyPhase 3
72
Omadacycline + MoxifloxacinPhase 3
72
ZL-2306 (Nirapairb) + Placebo ComparatorPhase 3
72
Xanomeline and Trospium Chloride Capsules + PlaceboPhase 3
72
ZL-2306(nirapairb) + PlacebosPhase 3
72